Skip to Main Content

Author Details

Kimberly R Jordan
University of Colorado Anschutz Medical Campus
2002
51
21
PMIDPaper TitleJournal TitlePublished Year
36378549Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.Clin Cancer Res2023
37733781A platform-independent framework for phenotyping of multiplex tissue imaging data.PLoS Comput Biol2023
37066339Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in <i>CTNNB1</i>-mutated endometrial cancer.bioRxiv2023
36577897Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.Nat Cancer2023
36865165Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models.bioRxiv2023
34711500Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.Cytotherapy2022
35704658SPF: A spatial and functional data analytic approach to cell imaging data.PLoS Comput Biol2022
35500934Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.J Immunol2022
35725622On clustering for cell-phenotyping in multiplex immunohistochemistry (mIHC) and multiplexed ion beam imaging (MIBI) data.BMC Res Notes2022
36434392A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.Nat Cancer2022
36419897Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models.Front Oncol2022
35217532Specialized interferon action in COVID-19.Proc Natl Acad Sci U S A2022
33097963Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.Cancer Immunol Immunother2021
35854837Adamantinomatous craniopharyngioma associated with a compromised blood-brain barrier: patient series.J Neurosurg Case Lessons2021
33758879The COVIDome Explorer Researcher Portal.medRxiv2021
33724185Seroconversion stages COVID19 into distinct pathophysiological states.Elife2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
34885092Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4<sup>+</sup> BTLA<sup>+</sup> T Cells in Tumor Microenvironment of Mycosis Fungoides.Cancers (Basel)2021
34615692The Spatial Context of Tumor-Infiltrating Immune Cells Associates with Improved Ovarian Cancer Survival.Mol Cancer Res2021
34074778Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.Proc Natl Acad Sci U S A2021
34348131The COVIDome Explorer researcher portal.Cell Rep2021
31513709Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.J Clin Endocrinol Metab2020
32071067High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes.Immunohorizons2020
33225939Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.Breast Cancer Res2020
33330890Seroconversion stages COVID19 into distinct pathophysiological states.medRxiv2020
33352903Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity.Int J Mol Sci2020
32843493HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery.J Immunother Cancer2020
30944125Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.Clin Cancer Res2019
31781510IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.Front Oncol2019
31722205Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.Cell Rep2019
30736857Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.J Immunother Cancer2019
30323566Characterization of clinical grade CD19 chimeric antigen receptor T cells produced using automated CliniMACS Prodigy system.Drug Des Devel Ther2018
30121453Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.Int Immunopharmacol2018
29233375Pharmacy student perspectives regarding curricular renewal with experiential alignment.Curr Pharm Teach Learn2017
28108766Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.Cancer Immunol Immunother2017
28179538The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients.J Leukoc Biol2017
22941561Influence of human immune cells on cancer: studies at the University of Colorado.Immunol Res2013
24106273Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.J Biol Chem2013
24072401Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.Cancer Immunol Immunother2013
23161490Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.Cancer Res2013
21962733DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.J Surg Res2012
22350070TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.Cancer Immunol Immunother2012
20133772Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.Proc Natl Acad Sci U S A2010
20856901The Goldilocks model for TCR-too much attraction might not be best for vaccine design.PLoS Biol2010
19347845Vaccination of mice with baculovirus-infected insect cells expressing antigenic proteins.Curr Protoc Immunol2009
18097019Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.J Immunol2008
18329760Age-dependent tolerance to an endogenous tumor-associated antigen.Vaccine2008
16623770Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands.Immunol Rev2006
16932807Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.J Clin Invest2006
12525567Peripheral blood-derived bovine dendritic cells promote IgG1-restricted B cell responses in vitro.J Leukoc Biol2003
  • 1 - 50 of 51

Recommended Authors

Amrita Basu
University of California San Francisco
Career Start Year 2018
Number of shared co-authors 0
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Dipti Vijayan
QIMR Berghofer Medical Research Institute
Career Start Year 2011
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Ansuman T Satpathy
Stanford University
Career Start Year 2005
Number of shared co-authors 0
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 1
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 0
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
Craig L Slingluff
University of Virginia
Career Start Year 1987
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 0
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 3
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 0
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 4
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 0
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 1

Collaborators

Martin D McCarter
University of Colorado School of Medicine
Co-authored papers 10
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers 9
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 7
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers 6
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 5
Richard D Schulick
University of Colorado School of Medicine
Co-authored papers 5
Sana D Karam
University of Colorado School of Medicine
Co-authored papers 5
Seth Russell
University of Colorado School of Medicine
Co-authored papers 5
Dexiang Gao
University of Colorado Anschutz Medical Campus
Co-authored papers 5
Laurel B Darragh
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 4
Andy Phan
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Benjamin Van Court
University of Colorado
Co-authored papers 3
Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-authored papers 3
Ayman Oweida
Universite de Sherbrooke
Co-authored papers 3
Jason Williams
University of Colorado Denver
Co-authored papers 3
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Fabia Gamboni
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Karyn A Goodman
Mount Sinai Hospital
Co-authored papers 3
Rene Gonzalez
University of Colorado Anschutz Medical Campus
Co-authored papers 3
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 3
Marco Del Chiaro
University of Colorado
Co-authored papers 2
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers 2
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers 2
Tellen D Bennett
Adult and Child Center for Outcomes Research and Delivery Science
Co-authored papers 2
Christopher C Porter
Emory University School of Medicine
Co-authored papers 1
David Lagares
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Casey S Greene
Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Michael Angelo
Co-authored papers 1
Brisa Pe??a
Cardiovascular Institute, University of Colorado Denver Anschutz Medical Campus
Co-authored papers 1
Release 1.2